- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Therapies for Advanced Squamous Cell Anal Cancer
Authors
Keywords
Advanced anal cancer, Systemic therapy, Chemotherapy, Cisplatin, Carboplatin, 5-Fluorouracil, Capecitabine, Paclitaxel, Docetaxel, Mitomycin, Targeted therapy, Cetuximab, Panitumumab, Immunotherapy, Pembrolizumab, Nivolumab, LY2606368, HPV, InterAACT, Epitopes-HPV02
Journal
Current Oncology Reports
Volume 20, Issue 7, Pages -
Publisher
Springer Nature
Online
2018-05-04
DOI
10.1007/s11912-018-0698-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anal Cancer Risk Among People With HIV Infection in the United States
- (2018) Vivian Colón-López et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Characterization and Response to Cetuximab in a Patient with Refractory Squamous Cell Anal Carcinoma
- (2018) Sara De Dosso et al. TUMORI
- Worldwide burden of cancer attributable to HPV by site, country and HPV type
- (2017) Catherine de Martel et al. INTERNATIONAL JOURNAL OF CANCER
- Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group Trial (E3205)
- (2017) Madhur K. Garg et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial
- (2017) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
- (2017) Van K Morris et al. LANCET ONCOLOGY
- Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal
- (2017) Van Morris et al. MOLECULAR CANCER RESEARCH
- Platinum‐Fluoropyrimidine and Paclitaxel‐Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients
- (2017) Francesco Sclafani et al. ONCOLOGIST
- EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience
- (2017) Dae Won Kim et al. ONCOLOGY
- Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma
- (2017) Elizabeth L. Yanik et al. JAMA Oncology
- Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes
- (2016) J. H. Chung et al. ANNALS OF ONCOLOGY
- Epidermal growth factor receptor inhibition in metastatic anal cancer
- (2016) Jane E. Rogers et al. ANTI-CANCER DRUGS
- Systemic therapy for advanced anorectal squamous cell carcinomas: A single institutional experience.
- (2016) Patrick McKay Boland et al. JOURNAL OF CLINICAL ONCOLOGY
- An update on anal neoplasia
- (2015) Jean-François Fléjou HISTOPATHOLOGY
- InterAACT: An international multicenter open label randomized phase II advanced anal cancer trial comparing cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus carboplatin (CBDCA) plus weekly paclitaxel (PTX) in patients with inoperable locally recurrent (ILR) or metastatic disease.
- (2015) Francesco Sclafani et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive Immune Resistance: How Cancer Protects from Immune Attack
- (2015) A. Ribas Cancer Discovery
- Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
- (2015) Brandon G. Smaglo et al. Oncotarget
- Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
- (2014) R. Glynne-Jones et al. EJSO
- British HIV Association guidelines for HIV-associated malignancies 2014
- (2014) et al. HIV MEDICINE
- Carboplatin and Paclitaxel Treatment Is Effective in Advanced Anal Cancer
- (2014) Richard Kim et al. ONCOLOGY
- Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab
- (2014) Mohamad Khawandanah et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial†
- (2013) E. Deutsch et al. ANNALS OF ONCOLOGY
- DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma
- (2013) S. Kim et al. ANNALS OF ONCOLOGY
- Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
- (2013) S. Lyford-Pike et al. CANCER RESEARCH
- Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial
- (2013) Roger D James et al. LANCET ONCOLOGY
- EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
- (2012) A Paliga et al. BRITISH JOURNAL OF CANCER
- Epidermal Growth Factor Receptor and K-RAS status in two cohorts of squamous cell carcinomas
- (2010) Nancy Van Damme et al. BMC CANCER
- Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
- (2010) J Northover et al. BRITISH JOURNAL OF CANCER
- Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review
- (2010) T Lampejo et al. BRITISH JOURNAL OF CANCER
- Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status
- (2009) Nadine Lukan et al. ONCOLOGY
- Activity of paclitaxel in metastatic squamous anal carcinoma
- (2008) Thierry Alcindor INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started